The post Remdesivir and tocilizumab more effective in treating Covid patients : Study appeared first on The Edge Media.
]]>The doctors studied the effect of remdesivir and tocilizumab on 521 patients at KEM hospital and compared it with retrospective clinical details of 214 patients from a time when they were not available as experimental drugs for Covid (from March 23 to May 31, 2020).
Of the 334 (64%) patients discharged after being given either or both the drugs, only five needed supplemental oxygen. The doctors’ observational study was published on July 1 in the Journal of the Association of Physicians of India.
The doctors found that hospitalisation (median days) was maximum in the tocilizumab group — 47 days. It was 14 days in the remdesivir group and 10 in the group receiving both drugs. Patients requiring vasopressors, medicines that help in tightening blood vessels and raising blood pressure, had higher mortality, said Dr Vishal Gupta, associate professor, intensive care, department of medicine, from the hospital and also the principal investigator of the study.
The post Remdesivir and tocilizumab more effective in treating Covid patients : Study appeared first on The Edge Media.
]]>The post Remdesivir production increased to 119L per month after shortage appeared first on The Edge Media.
]]>The license has been granted to 7 domestic manufacturers and all of them were asked to ramp up the production quickly. The Ministry of Chemicals and Fertilizers in a statement has called this the result of combined efforts of the government and the manufacturers.
Production capacity of #Remdesivir has been increased from 38 lakh vials to nearly 119 lakh vials per month
Substantial increase in number of manufacturing sites of Remdesivirhttps://t.co/YL2S9dKygg#Unite2FightCorona pic.twitter.com/9YIKMNkOht
— PIB in Maharashtra
(@PIBMumbai) May 17, 2021
The production has been boosted with the help of supplies from foreign countries with the help of the Union Ministry of external affairs. With the accelerated approval, the number of manufacturing sites has also gone up from 22 to 60.
The data regarding the allocation of Remdesivir to the States and Union Territories have also been shared by the government. The state governments have also been asked to monitor proper distribution.
The post Remdesivir production increased to 119L per month after shortage appeared first on The Edge Media.
]]>The post 850 injections of ramdesvir stolen from Bhopal’s Hamidia Hospital appeared first on The Edge Media.
]]>
In many cities including the capital Bhopal, Indore and Jabalpur, people are plagued by their black marketing. Meanwhile, news of the theft of Remedisvir in the state government hospital has also come to light.
The box of 850 injections of Remadecivir has been stolen from Bhopal’s largest government Hamidia Hospital. Orders have been ordered to investigate this.
The government has supplied it by helicopter in many cities amidst the shortage of Remediesvir in the state. The 850-injection box was delivered to Hamidia Hospital on Friday and was to be given to patients on Saturday, but its entire box was already stolen.
On Saturday morning, there was a stir in the hospital as soon as the injection from the store room was reported missing.
The hospital management is now ascertaining whether any other drug has been stolen with the injection. However, the top officials of the hospital are still refraining from speaking anything openly about it.
When asked about this, Superintendent of Hospital ID Chaurasia admitted the theft, but made an excuse for the meeting.
The post 850 injections of ramdesvir stolen from Bhopal’s Hamidia Hospital appeared first on The Edge Media.
]]>The post Black marketing of Remdesivir during second wave appeared first on The Edge Media.
]]>Remadecivir injection, which is believed to be helpful in the prevention of corona, is getting black marketed. Police has taken action against such black marketing in Indore in Madhya Pradesh and Kanpur in Uttar Pradesh. 3 black marketing men have been arrested in Indore. These people were selling Remadecivir at about Rs 20,000 per dose more than the right price. In Kanpur, 265 doses of Remedisvir have been seized.
Nepal relies on the life-saving Remedisvir drug found in the Indian market. Until the vaccine is made, the use of this medicine is being used in the treatment of covid-19 all over the world. Although the drug is not seen as a treatment for the virus, it has played an important role in getting patients out of an important medical stage.
Sapna ‘s father was admitted to a private hospital in Kathmandu and was being treated by covid-19. During this time, he asked for chemist drug from the chemist, then it was not available in Nepal. The chemist then contacted in India and ordered the drug Remedesivir. Sapna said that her chemist brought the medicine from India and now her father is out of danger. If the drug was not available in India, the situation could be worrisome.
Sapna said that the medicine is available in India for seven thousand rupees, which she found in 20 thousand Nepalese rupees. The government of Nepal has given permission to three companies for the purchase of medicine from abroad, including India and the United States.
Virus expert Dr. Prabhat Adhikari said that if we can import it in large quantities, then there will be no need to pay additional fees to the relatives of patients who are fighting the battle of covid-19 infection. Hopefully, the drug will be imported from India and the US as soon as possible.
The post Black marketing of Remdesivir during second wave appeared first on The Edge Media.
]]>The post Zydus Cadila Launches Remdesivir Under The Brand Name ‘Remdac’ appeared first on The Edge Media.
]]>
Priced at Rs 2,800 per 100 mg vial, Remdac is the most economical Remdesivir brand in India, Zydus Cadila said in a regulatory filing. The company said the drug will be made available across India through the group’s strong distribution chain reaching out to government and private hospitals treating COVID-19 patients.
Remdac is the most affordable drug as we would like to enable patients to have access to this critical drug in the treatment of COVID-19, Cadila Healthcare Managing Director Dr. Sharvil Patel said. Through the course of this pandemic, the company’s efforts have been focused on supporting people in this healthcare crisis, whether it is through developing vaccines, ramping up production and distribution of critical drugs and therapies, making diagnostic tests available or exploring new treatment options, Patel added.
In June this year, Zydus had entered into a non-exclusive agreement with Gilead Sciences Inc. to manufacture and sell Remdesivir, the investigational drug, which has been issued an emergency use authorization by the US Food and Drug Administration (USFDA) to treat patients suffering from severe symptoms of COVID-19.
– PTI
The post Zydus Cadila Launches Remdesivir Under The Brand Name ‘Remdac’ appeared first on The Edge Media.
]]>The post Mylan gets permission to manufacture and market the anti-viral drug remdesivir for “restricted emergency use” on hospitalized COVID-19 patients appeared first on The Edge Media.
]]>Written informed consent of each patient is required before the use of the drug while active post-marketing surveillance data and reporting of serious adverse events have to be submitted.
On June 21, Hetero and Cipla were given permission to manufacture and market the drug on the same conditions.
The Union Health ministry in its ‘Clinical Management Protocols for COVID-19’ recommended the use of the drug in COVID-19 patients with moderate stages of the illness (those on oxygen support).
The drug has been included as an investigational therapy only for restricted emergency use purposes. It is not recommended for those with severe renal impairment and high level of liver enzymes, pregnant and lactating women, and those below 12 years, the document stated. The drug, administered in the form of an injection, should be given at a dose of 200 mg on day one followed by 100 mg daily for five days. — PTI
The post Mylan gets permission to manufacture and market the anti-viral drug remdesivir for “restricted emergency use” on hospitalized COVID-19 patients appeared first on The Edge Media.
]]>